Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of LRFN5 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | ELISA,IHC,WB-Ce |
More info about LRFN5 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB16717 |
| Product name: | LRFN5 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of LRFN5. |
| Gene id: | 145581 |
| Gene name: | LRFN5 |
| Gene alias: | C14orf146|DKFZp686G0210|FIGLER8|FLJ30803|SALM5 |
| Gene description: | leucine rich repeat and fibronectin type III domain containing 5 |
| Immunogen: | A synthetic peptide corresponding to C-terminus 16 amino acids of human LRFN5. |
| Protein accession: | Q96NI6 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.5-1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.02% sodium azide) |
| Storage instruction: | Store at 4°C for three months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Immunohistochemistry of LRFN5 in mouse brain tissue with LRFN5 polyclonal antibody (Cat # PAB16717) at 5 ug/mL . |
| Applications: | ELISA,IHC,WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | The leucine-rich repeat as a protein recognition motif.Kobe B, Kajava AV. Curr Opin Struct Biol. 2001 Dec;11(6):725-32. |